AU2002215223A1 - Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts - Google Patents

Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts

Info

Publication number
AU2002215223A1
AU2002215223A1 AU2002215223A AU1522302A AU2002215223A1 AU 2002215223 A1 AU2002215223 A1 AU 2002215223A1 AU 2002215223 A AU2002215223 A AU 2002215223A AU 1522302 A AU1522302 A AU 1522302A AU 2002215223 A1 AU2002215223 A1 AU 2002215223A1
Authority
AU
Australia
Prior art keywords
preventive
salts
containing fused
heterocycle compounds
diabetes containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002215223A
Inventor
Fuminori Kato
Hirohiko Kimura
Ryuji Miyamoto
Masato Omatsu
Kazuhiro Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ishihara Sangyo Kaisha Ltd
Original Assignee
Ishihara Sangyo Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ishihara Sangyo Kaisha Ltd filed Critical Ishihara Sangyo Kaisha Ltd
Publication of AU2002215223A1 publication Critical patent/AU2002215223A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU2002215223A 2000-11-17 2001-11-16 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts Abandoned AU2002215223A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000351764 2000-11-17
JP2000-351764 2000-11-17
PCT/JP2001/010061 WO2002040485A1 (en) 2000-11-17 2001-11-16 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts

Publications (1)

Publication Number Publication Date
AU2002215223A1 true AU2002215223A1 (en) 2002-05-27

Family

ID=18824765

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002215223A Abandoned AU2002215223A1 (en) 2000-11-17 2001-11-16 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts

Country Status (7)

Country Link
US (1) US7067520B2 (en)
EP (1) EP1334973A1 (en)
CN (1) CN1474818A (en)
AU (1) AU2002215223A1 (en)
CA (1) CA2429067A1 (en)
RU (1) RU2003117719A (en)
WO (1) WO2002040485A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2842809A1 (en) * 2002-07-26 2004-01-30 Greenpharma Sas NOVEL SUBSTITUTED PYRAZOLO [1,5-a] -1,3,5-TRIAZINES AND THEIR ANALOGUES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, USE AS A MEDICAMENT AND METHODS FOR THEIR PREPARATION
TW200413377A (en) * 2002-09-04 2004-08-01 Schering Corp Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7119200B2 (en) 2002-09-04 2006-10-10 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US7084271B2 (en) 2002-09-04 2006-08-01 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
US8673924B2 (en) 2002-09-04 2014-03-18 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
CA2497544C (en) 2002-09-04 2010-11-02 Schering Corporation Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors
MXPA05002570A (en) 2002-09-04 2005-09-08 Schering Corp Pyrazolopyrimidines as cyclin dependent kinase inhibitors.
US7196078B2 (en) 2002-09-04 2007-03-27 Schering Corpoartion Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
US8580782B2 (en) 2002-09-04 2013-11-12 Merck Sharp & Dohme Corp. Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
US7161003B1 (en) 2002-09-04 2007-01-09 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
ES2346204T3 (en) 2002-09-04 2010-10-13 Schering Corporation SUITABLE PYRAZOLOPIRIMIDINS FOR THE TREATMENT OF CANCER DISEASES.
US7205308B2 (en) 2002-09-04 2007-04-17 Schering Corporation Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
US20070027156A1 (en) * 2003-09-09 2007-02-01 Hisao Nakai Crf antagonists and heterobicyclic compounds
DE102004007076A1 (en) * 2004-02-13 2005-08-25 Bayer Cropscience Ag New imidazolopyrimidine derivatives useful for controlling unwanted microorganisms, e.g. phytopathogenic fungi
US7667036B2 (en) * 2004-08-13 2010-02-23 Teijin Pharma Limited Pyrazolo[1,5-a]pyrimidine derivatives
JPWO2006016715A1 (en) * 2004-08-13 2008-05-01 帝人ファーマ株式会社 Pyrazolo [1,5-a] pyrimidine derivatives
AU2006241684A1 (en) 2005-04-28 2006-11-09 Ajinomoto Co., Inc. Novel lactam compound
WO2007017678A1 (en) * 2005-08-09 2007-02-15 Eirx Therapeutics Limited Pyrazolo[1,5-a] pyrimidine compounds and pharmaceutical compositions containing them
EP1931641B1 (en) * 2005-09-09 2010-08-25 Schering Corporation NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
EP1931676B1 (en) * 2005-10-06 2011-11-16 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
WO2009041663A1 (en) * 2007-09-28 2009-04-02 Kyowa Hakko Kirin Co., Ltd. Agent for prevention and/or treatment of skin diseases
WO2009077334A1 (en) * 2007-12-14 2009-06-25 F. Hoffmann-La Roche Ag Novel imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives
DE102008050882B4 (en) 2008-10-09 2019-03-28 Leuze Lumiflex Gmbh + Co. Kg sensor arrangement
US8343977B2 (en) 2009-12-30 2013-01-01 Arqule, Inc. Substituted triazolo-pyrimidine compounds
CA2792102C (en) 2010-03-05 2015-06-09 Kyowa Hakko Kirin Co., Ltd. Pyrazolopyrimidine derivative
WO2012088682A1 (en) * 2010-12-29 2012-07-05 Shanghai Fochon Pharmaceutical Co Ltd. 2-(3-aminopiperidin-1-yl)-[1,2,4]triazolo[1,5-c]pyrimidine-5,7(3h,6h)-dione derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
WO2012178125A1 (en) 2011-06-22 2012-12-27 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
EP2734520B1 (en) 2011-07-19 2016-09-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
KR20140075698A (en) 2011-09-02 2014-06-19 교와 핫꼬 기린 가부시키가이샤 Chemokine receptor activity regulator
AU2012325909B2 (en) 2011-10-20 2016-06-09 Glaxosmithkline Llc Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
JP2014530870A (en) * 2011-10-20 2014-11-20 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ Substituted bicyclic azaheterocycles and analogs as sirtuin regulators
EP2768833A4 (en) * 2011-10-20 2015-04-15 Sirtris Pharmaceuticals Inc Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
AU2013344716B2 (en) 2012-11-16 2018-03-01 University Health Network Pyrazolopyrimidine compounds
PL3808749T3 (en) 2012-12-07 2023-07-10 Vertex Pharmaceuticals Incorporated Pyrazolo[1,5-a]pyrimidines useful as inhibitors of atr kinase for the treatment of cancer diseases
EP2970289A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Inc. Compounds useful as inhibitors of atr kinase
EP2970288A1 (en) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase
WO2014143240A1 (en) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
JP6543252B2 (en) 2013-12-06 2019-07-10 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 2-Amino-6-fluoro-N- [5-fluoro-pyridin-3-yl] pyrazolo [1,5-a] pyrimidine-3-carboxamide compounds useful as ATR kinase inhibitors, their preparation, their different solid forms And radiolabeled derivatives
MX2016015874A (en) 2014-06-05 2017-03-27 Vertex Pharma Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyrid in-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof.
PT3157566T (en) 2014-06-17 2019-07-11 Vertex Pharma Method for treating cancer using a combination of chk1 and atr inhibitors
CA3000684A1 (en) 2015-09-30 2017-04-06 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna damaging agents and atr inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE255734C (en) *
US3202512A (en) * 1962-02-23 1965-08-24 Eastman Kodak Co Photographic silver halide emulsions stabilized with tetrazaindene compounds
GB1040161A (en) * 1964-01-29
JPH07168303A (en) * 1993-12-13 1995-07-04 Fuji Photo Film Co Ltd Silver halide photographic sensitive material and image forming method using same
KR19990008451A (en) * 1995-05-09 1999-01-25 페라스타르크 Pyrazolo- (1,5a) -pyrimidine, its preparation method and its use
JP2002501532A (en) 1997-05-30 2002-01-15 メルク エンド カンパニー インコーポレーテッド Novel angiogenesis inhibitors
EP1149835A4 (en) 1999-01-29 2002-08-21 Sumitomo Chemical Co Fat accumulation inhibitory agents
JP2001302666A (en) * 1999-09-21 2001-10-31 Nissan Chem Ind Ltd Azole-condensed heterocyclic anilide compound and herbicide

Also Published As

Publication number Publication date
CN1474818A (en) 2004-02-11
WO2002040485A1 (en) 2002-05-23
US20040043998A1 (en) 2004-03-04
CA2429067A1 (en) 2002-05-23
RU2003117719A (en) 2004-10-27
EP1334973A1 (en) 2003-08-13
US7067520B2 (en) 2006-06-27

Similar Documents

Publication Publication Date Title
AU2002215223A1 (en) Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts
AU4612300A (en) Preventive or therapeutic drugs for diabetes
HK1064035A1 (en) Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
AU1071301A (en) Pharmaceutical compounds
IL156916A0 (en) Pharmaceutical composition having reduced tendency for drug crystallization
HUP0002628A2 (en) Pharmaceutical combinations for treating diabetes
AU2001271037A1 (en) Pharmaceutical compositions containing dds compounds
AU1724301A (en) Hydrogel-driven layered drug dosage form
AU2002214006A1 (en) Drugs for diabetes
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU6827800A (en) Aqueous pharmaceutical composition containing moxifloxacin or salts thereof
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
IL145632A0 (en) Pharmaceutical compounds
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU3945501A (en) Apparatus for dosage of medicaments
AU5722900A (en) Pharmaceutical compounds
GB9903784D0 (en) Pharmaceutical compounds
AU6480299A (en) Pharmaceutical compounds
HUP9904393A2 (en) Medicament for defence of retching of dogs containing azithromycin
AU2882699A (en) Stabilizing composition for pharmaceutical dosage forms
AU2001292578A1 (en) Pharmaceutical compounds
GB2373499B (en) Pharmaceutical compounds
AU5184599A (en) Pharmaceutical compounds
AU2002342940A1 (en) New pharmaceutical compounds